Suppr超能文献

杜普伊特伦挛缩症:生物分子层面及治疗前景的最新进展

Dupuytren's contracture: an update of biomolecular aspects and therapeutic perspectives.

作者信息

Cordova A, Tripoli M, Corradino B, Napoli P, Moschella F

机构信息

Dipartimento di Discipline Chirurgiche ed Oncologiche, Cattedra di Chirurgia Plastica e Ricostruttiva Università di Palermo, Via del Vespro, Palermo, Italy.

出版信息

J Hand Surg Br. 2005 Dec;30(6):557-62. doi: 10.1016/j.jhsb.2005.07.002. Epub 2005 Sep 15.

Abstract

The so-called fibrogenic cytokines, able to induce the growth of fibroblasts and their differentiation into myofibroblasts and to stimulate their production of extracellular matrix, are involved in the genesis of Dupuytren's contracture. Although many studies have been made of biomolecular aspects of palmar fibromatosis, practical applications from them are still far from imminent because of the real difficulty of blocking their action in vivo, even in a chronic, progressive lesion such as Dupuytren's disease. Consequently, surgical excision of the palmar fascia still remains the treatment of choice.

摘要

所谓的促纤维化细胞因子,能够诱导成纤维细胞生长并使其分化为肌成纤维细胞,还能刺激其产生细胞外基质,参与了掌腱膜挛缩症的发病过程。尽管已经对掌部纤维瘤病的生物分子方面进行了许多研究,但由于在体内阻断其作用存在实际困难,即使是在像掌腱膜挛缩症这样的慢性进行性病变中,从这些研究中得出的实际应用仍远未实现。因此,手术切除掌腱膜仍然是首选的治疗方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验